Healthcare-associated infections remain a significant challenge for hospitals and care facilities, and few pathogens are as persistent as Clostridioides difficile (C. difficile). The bacterium produces highly resilient spores that can survive on surfaces for weeks or even months and resist many commonly used disinfectants, making effective environmental hygiene a critical part of infection prevention.
To help healthcare professionals meet this challenge, Kiilto is introducing Ultrasol Oxy® Wipes, a new high-level disinfectant wipe designed for demanding healthcare environments. The product combines broad-spectrum efficacy, practical usability, and fast action in a ready-to-use format, supporting healthcare teams in maintaining high hygiene standards while managing busy clinical workflows.
One of the key challenges in controlling C. difficile is that spores can remain viable on high-touch surfaces, contributing to indirect transmission between patients. Ultrasol Oxy® Wipes were developed specifically for these demanding conditions.
The wipes demonstrate efficacy against C. difficile spores according to both EN 17126 and EN 17846, the latter verifying sporicidal efficacy with mechanical wiping action under practical-use conditions.
Notably, the product is active against C. difficile in dirty conditions with a contact time of just five minutes, helping healthcare teams reduce turnaround times without compromising infection control.
Beyond sporicidal performance, the wipes provide full-spectrum efficacy against bacteria, viruses, fungi, mycobacteria, and spores, while combining cleaning and disinfection in a single step. The ready-to-use flowpack format supports straightforward, consistent application at the point of care.
Ultrasol Oxy® Wipes are also dual registered as both a Medical Device Class IIb and a Biocide (PT2/PT4), making them suitable for a wide range of applications in healthcare environments.
As healthcare facilities continue to strengthen infection prevention measures, Ultrasol Oxy® Wipes offer a practical new tool for addressing one of healthcare’s most resilient contamination challenges: C. difficile spores. By combining proven sporicidal efficacy, short contact times and ease of use, the product helps support safer care environments for both patients and healthcare professionals.